It is shown that rifampicin, and especially the related antibiotic 2',6'-dimethyl-N(4')-benzyl-N(4')-
Rifamycin and its derivatives constitute a group of antibiotics that have been developed particularly for use against mycobacteria. Their mode of action involves the bacterial RNA polymerase (1). After the discovery that these drugs could also inhibit the replication of certain viruses, particularly adenovirus and vaccinia (2) (3) (4) , it became of interest to explore the extent and possibly determine the nature of this antiviral activity. Toward this end, we obtained some samples of these materials in April of 1970* whose structures are shown in Fig. 1 .
There followed the discovery of the RNA-dependent DNA polymerase in oncogenic RNA virus by Temin and Mizutani (5) and by Baltimore (6) . An extensive discussion ensued about the distribution of this enzyme (particularly in virions and in cells from a variety of tumors) and the inhibition of the enzyme by some of the rifamycin derivatives (7) (8) (9) (10) .
It thus became clear that the possibility was real that one or more of these rifamycin derivatives could inhibit the transformation of cells from the normal into the neoplastic state. We therefore undertook to determine whether or not such a transformation could be affected by some of the derivatives which we had available.
Such a possibility had already been suggested by the experiments of Diggelmann and Weissmann (11) , in which Rous sarcoma virus transformation of chick fibroblast monolayers had been inhibited by rifampicin at a concentration of Abbreviations: DMB-rifampicin, 2',6'-dimethyl-N(4')-benzyl-N(4')-[desmethyljrifampicin, previously known as dimethyl-N-benzyl-N-des-methyl rifampicin; FFU, focus-forming units. Moloney murine sarcoma virus was obtained from J. Moloney, National Institutes of Health, as a tumor homogenate. It has been passaged four times in a Swiss-derived high-passage mouse embryo cell line and assayed for focus-forming units (FFU) in BALB/3T3 cells. The virus pool used in these experiments titered 8.5 X 106 FFU/ml. Vesicular stomatitis virus, New Jersey serotype, and methods used for its growth and assay, have been described (12) .
Assay of Moloney virus
A modification of the method described by Hartley and Rowe (13) was used for the focus assay. Flasks were seeded with 1-2 X 106 cells in 25 ml of growth medium and incubated at 37°C for 24 hr. After the removal of fluids, virus was introduced in 0.5 ml of growth medium and allowed to adsorb on the monolayer for 90 min at 37°C. 25 ml of growth medium was then added and the cultures were returned to the incubator. After 3 days the cultures were fluid-changed, and foci of transformed cells were counted at day 7.
The antibiotics were dissolved in dimethylsulfoxide at 1 mg/ml. In the control experiments (absence of drug) the equivalent amount of Me2SO was added without drug.
RESULTS AND DISCUSSION
Our first exploratory experiments defined the concentration region of useful activity of the drugs in the tissue cultures. Concentrations ) 20 pg/ml of DMB-rifampicin produced grossly visible toxic effects. Even 10 ug/ml of DMB-rifampicin seemed to slow the growth of both transformed and nontransformed cells during the early period, but both cell lines showed a net gain in number on the seventh day after inoculation. Rifampicin itself had little effect at 10 Ag/ml (see Table  2 ).
The results of one experiment are shown in Table 1 . It is quite clear that DMB-rifampicin is a potent inhibitor of the transformation process at 10 Ag/ml. No foci were visible even though the control shows over 1000 foci/flask. It is also clear that the drug inhibits virus replication as well. Rifampicin at 10 ug/ml also shows a slight inhibition of focus formation as well as some inhibition of virus replication. A more explicit and broader experiment was then performed, using a single dose of drug at a concentration of 0lAg/ml,the resultsof which are shown in Table 2 . Here it is again quite clear that the most potent drug we have so far studied is the DMB-rifampicin, which totally inhibits focus formation at 10 ug/ml. That not all RNA viruses are subject to this inhibition is demonstrated by the fact that vesicular stomatitis virus, which is not oncogenic but cytolytic and does not carry the RNA-or The same procedure as described in Table 1 was utilized to infect BALB/3T3 cultures with an estimated dose of 500 FFU of MSV.
The antibiotics were added to the growth media (including fluid change) at a final concentration of 10 usg/ml. FFU were counted, the supernatant fluid was assayed for yield of infectious virus, and the number of cells per flask was counted at day 7. These data are from the last of eight separate experiments conducted. Although the figures varied between experiments, the data have followed a consistent pattern. * See Table 1. DNA-dependent DNA polymerase (14) , is in no way affected by this drug in its ability to replicate on BALB/3T3 cell tissue culture. A 48-hr control showed 1.9 X 108 plaqueforming units/ml, while the system containing 10 ,ug/ml of DMB showed 2.2 X 108 plaque-forming units/ml. The interaction of the rifampicins with the RNA-dependent DNA polymerase in vitro (9) displays the same pattern of sensitivity as is shown in these experiments which test the intracellular effects of the drugs, namely, that rifampicin is a less active inhibitor than DMB-rifampicin. The specificity of the effect is further indicated by the failure (data not shown) to inhibit vesicular stomatitis virus. It is also important to note that cell proliferation itself is somewhat inhibited at 10 ,g/ml of DMB-rifampicin, although only by about 60%. It is unlikely that a net increase in cell number occurred during the 24-hr period between seeding and introduction of the drug (15) . The 3-fold increase in cell number (from 1 X 106 to 3.1-3.5 X 106 on day 7) in the cultures containing DMB-rifampicin probably occurred after introduction of the drug; this is supported by the fact that 104 FFU were produced in these cultures. That the inhibitory action of DMB on focus formation and on the production of infectious virus is solely a function of the reduced number of cellular divisions seems unlikely since cell number increased 3-fold, while focus formation was apparently totally inhibited. A more detailed exploration of this effect, both in time and in quantity, must be made and eventually related to the molecular effects of the drug on the enzyme involved.
It is interesting to note in this connection that Scolnick et al. (16) have recently reported the presence in nontransformed BALB/3T3 cells of a small amount of RNA-dependent DNA polymerase which responded to the poly(A) poly(dT) template (16) . This in itself might be enough to account for our observation of reduced cell multiplication in the presence of the drug. However, it is altogether likely that other enzymes crucial to cell multiplication are also inhibited.
Another interesting observation, reported by Spiegelman (17) , is that a monocytic leukemia virus carried in an ascitic form in a rat and induced by treatment with dimethylbenzanthracene has an enzyme very similar to the one found in human leukemia cells. Spiegelman has reported the presence of a similar activity in various embryonic tissues (18, 19) . It seems that this enzyme, a DNA polymerase that is dependent on hybrid RNA DNA, may be common to cells that are growing and dividing rapidly. In fact, it may be an especially facile supplementary route for replacing DNA via the DNA to RNA to DNA route, particularly in view of the questions that are being raised regarding the function of the Kornberg enzyme in DNA replication (20) .
All of this tends to support the notion of a gene for this enzyme, and for other aspects of transformed cells, which may very well be present in an unexpressed form in what we believe to be normal cells (21) . Expression of such genes, then, may be triggered either by chemicals, perhaps even by radiation, and by viruses, with the last one possibly introducing new information into the cell as well. It remains to be seen how far such hypotheses can be developed in molecular terms.
NOTE ADDED IN PROOF
Recent data show focus inhibition without reduction in cell replication by exposure to a more highly purified sample of DMB-rifampicin (3 ,.g/ml) for 72 hr after infection with MSV, in an experiment analogous to that described in Table 2 .
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